| Authors: |
Friedrich C; Research and Development, Pharmaceuticals, Bayer AG, 13353, Berlin, Germany. christian.friedrich@bayer.com., Francke K; Research and Development, Pharmaceuticals, Bayer AG, 13353, Berlin, Germany., Birring SS; Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine and King's College Hospital, London, UK., van den Berg JWK; Department of Pulmonology, Isala Hospital, Zwolle, The Netherlands., Marsden PA; School of Biological Sciences, Faculty of Biology, Medicine and Health Sciences, University of Manchester and North West Lung Centre, Manchester University NHS Foundation Trust, Manchester, UK., McGarvey L; Wellcome Wolfson Institute of Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK., Turner AM; Institute of Applied Health Research, University of Birmingham, Birmingham, UK., Wielders P; Department of Pulmonary Diseases, Catharina Hospital, Eindhoven, The Netherlands., Gashaw I; Research and Development, Pharmaceuticals, Bayer AG, 13353, Berlin, Germany., Klein S; Research and Development, Pharmaceuticals, Bayer AG, 13353, Berlin, Germany., Morice AH; Hull York Medical School, University of Hull, Castle Hill Hospital, Cottingham, E Yorkshire, UK. |
